Hualan Biological Vaccine, Inc. engages in research and development, production and sales of human vaccines. Its products include various vaccines, genetically engineered biological products, and sales of self-produced products. The company was founded on November 9, 2005 and is headquartered in Xinxiang, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company